Related Experiment Video
Updated: Jan 11, 2026
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in
Sinan Altunoz1, Nazan Dolapoglu2, Ozgur Baykan3
1Department of Mental Health and Diseases, Balikesir Atatürk City Hospital, Balikesir, Turkey.
Introduction:
This study investigated the regulation of miRNA-132-3p on TGF-β levels and its association with OCD severity. We hypothesized that miRNA-132-3p and TGF-β influence OCD aetiology and severity, with their levels correlating with disease severity.
Methods:
The study included 48 OCD patients diagnosed via SCID-5-CV per DSM-V and 48 matched healthy controls. Blood samples were analysed for miRNA-132-3p and TGF-β using RT-PCR and ELISA. Participants completed Y-BOCS, symptom list, HAMA, HAMD, consent and sociodemographic forms.
Results:
OCD patients had significantly lower TGF-β levels (p = 0.008), negatively correlating with Y-BOCS scores (rs = -0.220, p = 0.045) and disease duration (rs = -0.473, p = 0.002). miRNA-132-3p levels were 1.92 times higher in OCD patients (p = 0.003), positively correlating with Y-BOCS scores (rs = 0.208, p = 0.045).
Conclusions:
Altered TGF-β and miRNA-132-3p levels may contribute to OCD pathophysiology by affecting BDNF regulation, inflammatory responses (Th1/Th2, Th17/Treg balance) and synaptic plasticity-related genes.
More Related Videos
Related Concept Videos
01:28Obsessive-Compulsive Disorder
01:16TGF - β Signaling Pathway
01:22MicroRNAs